Get the Stockscreener App
52.00
4.25%
-2.31
Vericel Corp stock is traded at $52.00, with a volume of 410.84K.
It is down -4.25% in the last 24 hours and down -12.69% over the past month.
See More
Previous Close:
$54.31
Open:
$54.91
24h Volume:
410.84K
Relative Volume:
1.12
Market Cap:
$2.92B
Revenue:
$226.84M
Net Income/Loss:
$3.55M
P/E Ratio:
742.86
EPS:
0.07
Net Cash Flow:
$-12.02M
1W Performance:
-8.92%
1M Performance:
-12.69%
6M Performance:
+8.13%
1Y Performance:
+8.04%
1-Day Range:
$51.84
$54.91
1-Week Range:
$51.84
$58.77
52-Week Range:
$39.12
$63.00
Vericel Corp Stock (VCEL) Company Profile
Name
Vericel Corp
Sector
Industry
Phone
(734) 930-5555
Address
64 SIDNEY ST., CAMBRIDGE, MA
Compare VCEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VCEL
Vericel Corp
|
52.00 | 2.92B | 226.84M | 3.55M | -12.02M | 0.07 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Vericel Corp Stock (VCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-09-24 | Initiated | Canaccord Genuity | Buy |
| Jun-20-24 | Initiated | TD Cowen | Buy |
| Jan-25-24 | Upgrade | Truist | Hold → Buy |
| Aug-08-23 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Nov-09-22 | Downgrade | Truist | Buy → Hold |
| Oct-14-22 | Resumed | Stephens | Overweight |
| Jan-11-21 | Downgrade | Oppenheimer | Outperform → Perform |
| Dec-18-20 | Initiated | Stephens | Overweight |
| Sep-17-20 | Initiated | Truist | Buy |
| Oct-09-19 | Initiated | H.C. Wainwright | Buy |
| Feb-28-19 | Downgrade | Needham | Buy → Hold |
| Aug-08-18 | Reiterated | Needham | Buy |
| Jul-16-18 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Apr-04-18 | Initiated | Leerink Partners | Outperform |
| Mar-06-18 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Mar-06-18 | Reiterated | Needham | Buy |
| Mar-05-18 | Reiterated | BTIG Research | Buy |
| Jun-21-17 | Initiated | BTIG Research | Buy |
| Mar-13-17 | Reiterated | Needham | Buy |
| Dec-22-16 | Initiated | Piper Jaffray | Overweight |
| Nov-09-16 | Reiterated | Needham | Buy |
| Apr-05-16 | Downgrade | BofA/Merrill | Buy → Neutral |
| Mar-11-16 | Upgrade | Needham | Hold → Buy |
View All
Vericel Corp Stock (VCEL) Latest News
New York State Common Retirement Fund Has $46.94 Million Stake in Vericel Co. (NASDAQ:VCEL) - MarketBeat
Kornitzer Capital Management Inc. KS Makes New Investment in Vericel Co. (NASDAQ:VCEL) - MarketBeat
TimesSquare Capital Management LLC Has $34.71 Million Stock Holdings in Vericel Co. (NASDAQ:VCEL) - MarketBeat
Vericel Co. (NASDAQ:VCEL) Shares Sold by Legato Capital Management LLC - MarketBeat
Allspring Global Investments Holdings LLC Cuts Stock Holdings in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel Co. (NASDAQ:VCEL) Shares Purchased by Congress Asset Management Co. - MarketBeat
Vericel director Kevin McLaughlin sells shares worth $388,250 - MSN
Yousif Capital Management LLC Trims Stock Position in Vericel Co. (NASDAQ:VCEL) - Defense World
Jonathan Siegal Sells 1,092 Shares of Vericel Co. (NASDAQ:VCEL) Stock - MarketBeat
Vericel Co. (NASDAQ:VCEL) Director Sells $156,250.00 in Stock - MarketBeat
Vericel (NASDAQ:VCEL) Sets New 52-Week HighHere's Why - MarketBeat
Vericel's principal accounting officer sells $67,693 in stock - MSN
Vericel's principal accounting officer sells $67,693 in stock By Investing.com - Investing.com Australia
Vericel director Robert Zerbe sells $156,250 in stock - Investing.com India
Vericel Co. (NASDAQ:VCEL) Insider Jonathan Siegal Sells 1,092 Shares - Armenian Reporter
Vericel director Robert Zerbe sells $156,250 in stock By Investing.com - Investing.com Canada
Conestoga Capital Advisors LLC Sells 6,300 Shares of Vericel Co. (NASDAQ:VCEL) - MarketBeat
Canaccord Genuity Group Increases Vericel (NASDAQ:VCEL) Price Target to $67.00 - MarketBeat
Vericel Corp [NASDAQ: VCEL] Sees Increase in Stock Value - Knox Daily
Vericel (NASDAQ:VCEL) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - Defense World
Brokerages Set Vericel Co. (NASDAQ:VCEL) PT at $62.14 - Defense World
Vericel Co. (NASDAQ:VCEL) Receives $62.14 Average Price Target from Analysts - MarketBeat
SG Americas Securities LLC Trims Stock Position in Vericel Co. (NASDAQ:VCEL) - MarketBeat
What 7 Analyst Ratings Have To Say About Vericel - Benzinga
Canaccord raises Vericel stock target to $67, maintains buy rating - Investing.com
Vericel Co. (NASDAQ:VCEL) Insider Sells $242,256.92 in Stock - MarketBeat
SG Americas Securities LLC Lowers Stock Holdings in Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel (NASDAQ:VCEL) Sets New 1-Year HighStill a Buy? - MarketBeat
VCEL Stock Touches 52-Week High at $61.5 Amidst Strong Growth - MSN
Park Avenue Securities LLC Takes $280,000 Position in Vericel Co. (NASDAQ:VCEL) - MarketBeat
Park Avenue Securities LLC Buys Shares of 5,099 Vericel Co. (NASDAQ:VCEL) - Defense World
Vericel (NASDAQ:VCEL) Stock Passes Above 200 Day Moving Average – Here’s What Happened - Defense World
Vericel (NASDAQ:VCEL) Stock Crosses Above Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Burns Pipeline 2024: In-depth Clinical Trials Analysis and Emerging Therapies Report by DelveInsight | MediWound, Kaken Pharma, Kerecis, Medline, Mallinckrodt Pharma, Avita Medical, Vericel Corp - The Globe and Mail
Equities Analysts Set Expectations for Vericel Q3 Earnings - MarketBeat
Vericel (NASDAQ:VCEL) Earns “Overweight” Rating from Stephens - Defense World
FY2024 EPS Estimates for Vericel Reduced by HC Wainwright - Defense World
FY2024 Earnings Estimate for Vericel Issued By HC Wainwright - MarketBeat
Vericel expects 2024 net revenue in range of $237 to $237.5 million - MSN
Analyst supports Vericel stock outlook citing MACI Arthro synergies and expansion plans - Investing.com
Vericel (NASDAQ:VCEL) Shares Gap DownShould You Sell? - MarketBeat
Vericel (NASDAQ:VCEL) Receives "Overweight" Rating from Stephens - MarketBeat
Vericel Corp Stock (VCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Vericel Corp Stock (VCEL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Hopper Jonathan Mark | Chief Medical Officer |
Feb 19 '25 |
Option Exercise |
0.00 |
1,750 |
0 |
64,590 |
| Colangelo Dominick | President and CEO |
Feb 18 '25 |
Option Exercise |
0.00 |
11,700 |
0 |
250,887 |
| Colangelo Dominick | President and CEO |
Feb 19 '25 |
Option Exercise |
0.00 |
8,938 |
0 |
254,402 |
| Flynn Sean C. | Chief Legal Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
5,325 |
0 |
4,650 |
| Flynn Sean C. | Chief Legal Officer |
Feb 19 '25 |
Option Exercise |
0.00 |
1,750 |
0 |
5,368 |
| Mara Joseph Anthony Jr | Chief Financial Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
7,379 |
0 |
20,509 |
| SIEGAL JONATHAN | Principal Accounting Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
2,920 |
0 |
3,706 |
| Halpin Michael | Chief Operating Officer |
Feb 18 '25 |
Option Exercise |
0.00 |
9,075 |
0 |
13,106 |
| Halpin Michael | Chief Operating Officer |
Feb 19 '25 |
Option Exercise |
0.00 |
2,813 |
0 |
14,107 |
| SIEGAL JONATHAN | Principal Accounting Officer |
Feb 19 '25 |
Sale |
56.72 |
1,710 |
96,991 |
1,206 |
0.27%
3.05%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):